ArticleRevista medica del Instituto Mexicano del Seguro Social2024
[Metastatic breast melanoma in a man: Case report].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant melanoma is a skin neoplasm that typically does not invade the breast, making its spread to the breast tissue in a male patient uncommon. When it metastasizes to the breast, it can present as a palpable mass or even be asymptomatic. Ultrasound allows for the detection of round hypoechoic lesions, while mammography detects well-defined nodules with increased density. The aim of this article is to describe the approach to a male patient with a breast mass and suspected melanoma, as well as the importance of immunohistochemistry for proper differentiation. Clinical Case: A 72-year-old male patient presented with a pigmented lesion on the sternum, an axillary tumor, and a right breast mass, which had been evolving for the past two years. He underwent resection, excisional biopsy, and simple mastectomy, respectively. superficial spreading melanoma with right breast metastases was documented. Immunohistochemistry supported the diagnosis, after positivity for HMB-45 and S100 was found in the examined samples. Conclusions: Metastatic melanoma in the male breast is an exceedingly rare finding. Immunohistochemistry plays a pivotal role in both diagnostic assessment and prognosis, as it guides treatment determination, which encompasses local and systemic interventions. For patients presenting as in this case, the optimal approach involves wide tumor resection with axillary lymph node dissection, coupled with adjuvant systemic therapy. Hence, case reporting is imperative to share diagnostic approaches in such patients and provide appropriate management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.